NEPH earnings

SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2026. Financial Highlights Net revenue was $5.2 million, compared to $4.9 million in the first quarter of 2025, up 7%Net income was $140,000, compared to a net income of $558,000 in the first quarter of 2025Adjusted EBITDA was $206,000, compared to $667,000 in the first quarter of 2025 "Q1 2026 represents another important milestone for Nephros, as we exceeded $5 million in revenue in a quarter the first time in our company's histor

SOUTH ORANGE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Thursday, May 07, 2026 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of th

Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Financial HighlightsFourth Quarter Ended December 31, 2025. Net revenue was $4.7 million, compared to $3.9 million in the fourth quarter of 2024, up 22%Net income was $62,000, compared to $349,000 during the same period in 2024Adjust

SOUTH ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth-quarter financial results on Thursday, March 12, 2026 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of

SOUTH ORANGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 6, 2025 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of

SOUTH ORANGE, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2025. Financial Highlights Net revenue was $4.4 million, compared to $3.3 million in the second quarter of 2024, up 36%Net income was $237,000, compared to a net loss of ($289,000) in the second quarter of 2024Adjusted EBITDA was $355,000, compared to ($133,000) in the second quarter of 2024 For the six months ended June 30, 2025: Net revenue was $9.3 million, compared to $6.8 million in the same period of 2024, up 37%Net income w

SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a replay of

Third-Quarter Net Revenue of $3.5 Million;Operational Improvements Result In First Profitable Quarter SOUTH ORANGE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2024. Financial Highlights* Net income of $0.2 million, compared to a net loss of $0.2 millionAdjusted EBITDA of $295,000, compared to $11,000Net revenue of $3.5 million, an 8% increase over Q2 2024; a decrease of 6% over Q3 prior year *Stated performance is relative to same period in the prior year unless otherwise no

SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 7, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternatively, a repl

Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2024. Financial Highlights* Net revenue of $3.3 million, a decrease of 8% over Q2 prior year; programmatic revenue (excluding emergency response revenue) increased 8% over Q2 prior yearNet loss of $0.3 million, compared to a net loss of $0.4 millionAdjusted EBITDA of ($133,000), compared to ($183,000) *Stated performance

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. Alternativ

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial HighlightsFourth Quarter Ended December 31, 2023 Net revenue from continuing operations was $3.3 million, compared to $2.6 million in the fourth quarter of 2022, up 27%Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2022Adjusted EBITDA from co

SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor R

Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities SOUTH ORANGE, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023. Financial Highlights* Third-quarter net revenue of $3.7 million, an increase of 55%;Third-quarter net loss from continuing operations of $0.2 million, compared to $1.3 million;Third-quarter

SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be added into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022;Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results SOUTH ORANGE, NJ, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2023. Financial Highlights* Net revenue from continuing operations of $3.5 million, an increase of 24%Net loss from continuing operations of $0.4 million, compared to $0.7 millionAdjusted EBITDA from continuing operations of ($0.2 million), compared to ($0.4 million) *Stat

SOUTH ORANGE, NJ, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be added into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

First-Quarter Net Revenue of $3.7 Million;Achieves Positive Cash Flow Months Earlier than Forecast SOUTH ORANGE, NJ, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2023. Financial Highlights* Net revenue from continuing operations of $3.7 million, an increase of 71%Net loss from continuing operations of $0.3 million, compared to $1.6 million.Adjusted EBITDA from continuing operations of $0.1 million, compared to ($1.2 million) *Stated performance is relative to same

SOUTH ORANGE, NJ , April 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023. Nephros expects net revenue for the quarter ended March 31, 2023 to be approximately $3.7 million, a 69% increase from the quarter ended March 31, 2022. "We are very pleased with first-quarter revenue, which we believe reflects the impact of recent investments in our field sales organization," said Andy Astor, President and Chief Executive Officer of Nephros. "It is noteworthy that while this quarter's re

Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Financial Highlights Fourth Quarter Ended December 31, 2022 – Consolidated Net revenue from continuing operations was $2.6 million, compared to $2.7 million in the fourth quarter of 2021, down 6% Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2

SOUTH ORANGE, NJ, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced it will file its fourth quarter and fiscal 2022 results on Wednesday, March 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page. A

Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;Active Customer Sites Continue to Climb SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the fourth quarter and fiscal year ended December 31, 2022. Net revenue for the quarter ended December 31, 2022, is expected to be approximately $2.6 million, a 6% quarter-over-quarter increase and a 6% decrease from the quarter ended December 31, 2021. Full-year 2022 net revenue is expected to be approximately $10

Third-Quarter Net Revenue of $2.4 Million; Active Customer Sites Increase 18% YoY to a New Record Level SOUTH ORANGE, NJ, Nov. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights* Net revenue from continuing operations of $2.4 million, a decrease of 7%Net loss from continuing operations of $1.1 million, compared to $0.7 millionAdjusted EBITDA loss from continuing operations of ($0.2 million), compared with ($0.3

SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 2, 2022 after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.

Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY SOUTH ORANGE, NJ, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has entered into a definitive agreement to sell its Pathogen Detection Systems ("PDS") business. The Company also announced preliminary revenue results for the third quarter ended September 30, 2022. Sale of PDS Business The company has entered into an asset purchase agreeme

Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase;Active Customer Sites Climb 21% to New Record SOUTH ORANGE, NJ, Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights* Net revenue of $2.8 million, an increase of 30%Net loss of $0.6 million, compared to $0.9 millionAdjusted EBITDA of ($0.2 million), compared with ($0.5 million) Consolidated Highlights* Net revenue o

SOUTH ORANGE, NJ, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 10, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. A replay of the call can be accessed until August 17th, 2022 at 1 (877) 344-7529 or 1 (41

Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%;Number of Active Customer Sites Climbs 21% Year-Over-Year SOUTH ORANGE, NJ, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary revenue results for the second quarter ended June 30, 2022. Net revenue for the quarter ended June 30, 2022 is expected to be approximately $2.9 million, a year-over-year increase of 27%. In addition, the number of customer sites that have purchased from Nephros during the trailing 12 months, which Nephros ref

First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2022. Financial Highlights Water Filtration Business Segment Highlights* Net revenue of $2.2 million, a decrease of 21% Net loss of $1.4 million, compared to $0.2 million Adjusted EBITDA of ($1.0 million), compared with ($0.3) million Consolidated Highlights* Net revenue of $2.2 million,

SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be joined into the Nephros conference call. A replay of the call can be accessed until May 11th, 2022 at 1 (877) 344-7529 or 1 (412) 317-

Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue of $2.8 Million, an 18% Year-Over-Year Increase;Reaffirms Fiscal Year 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue SOUTH ORANGE, NJ, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Financial HighlightsFourth Quarter Ended December 31, 2021– Water FiltrationBusiness Segment Net revenue was

SOUTH ORANGE, NJ, Feb. 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter financial results on Wednesday, February 23, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon joining, please ask to be added into the Nephros conference call. A replay of the call can be accessed until March 2, 2022 at 1 (877) 344-7529 or 1 (412)

Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an 18% Year-Over-Year Increase; Provides 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue SOUTH ORANGE, NJ, Jan. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the fiscal year ended December 31, 2021. Net revenue for 2021 is expected to be $10.4 million, the highest in the company's history and a 21% increase over 2020. Net revenue for th

Third Quarter Net Revenue of $2.6 MillionUp 24% Year-Over-Year and 16% Quarter-over-Quarter  SOUTH ORANGE, NJ, Nov. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced results for the three months ended September 30, 2021. Financial Highlights Water Filtration Business Segment Highlights* Net revenue of $2.6 million, an increase of 22%Net loss of $0.8 million, an increase of 92%Adjusted EBITDA of ($0.3 million) an improvement of 6% Consolidated Highlights* Net revenue of $2.6 million, an increase of 24%Net l

SOUTH ORANGE, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc.(NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on Thursday, November 4, 2021 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1-844-808-7106International access: 1-412-317-5285 Upon joining, please ask to be joined into the Nephros conference call. A replay of the call can be accessed until November 11, 2021 at 1-877-344-7529or 1-412-317-0088

Anticipates Net Revenue of $2.6 Million, a 24% Year-Over-Year Increase SOUTH ORANGE, NJ, Oct. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the third quarter of 2021. Net revenue for the quarter ended September 30, 2021 is expected to be approximately $2.6 million, a year-over-year increase of 24%. "We are quite pleased with these results, especially given the ongoing presence of the COVID-19 Delta variant," said Andy Astor, President and Chief Executive Officer. "Year-to-date revenue for t

Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to FDA for 510(k) Clearance SOUTH ORANGE, NJ, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (NASDAQ:NEPH), a leading biotechnology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced results for the three months ended June 30, 2021. Financial Highlights Water Filtration Business Segment Highlights* Net revenue increased 40% to $2.2 million  Net loss of $0.9 million, no change from 2020   Adjusted EBITDA improved by 23% to ($0.5 million) Conso